MedPath

UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
1943-01-01
Employees
8.1K
Market Cap
-
Website
http://www.utsouthwestern.edu

Efficacy of Oral vs. Intravenous Acetaminophen

Phase 4
Completed
Conditions
Postoperative Pain
Interventions
First Posted Date
2015-12-31
Last Posted Date
2020-04-21
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
110
Registration Number
NCT02643394
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Zale Lipshy University Hospital, Dallas, Texas, United States

Etomidate Versus Ketamine for Emergency Endotracheal Intubation: a Prospective Randomized Clinical Trial

Phase 4
Completed
Conditions
Respiratory Arrest
Cardiopulmonary Arrest
Interventions
Drug: Etomidate
Drug: Ketamine
Procedure: Emergency Endotracheal Intubation
Device: Mechanical Ventilation
First Posted Date
2015-12-31
Last Posted Date
2021-12-15
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
801
Registration Number
NCT02643381
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Parkland Hospital, Dallas, Texas, United States

Gemfibrozil for Nicotine Smoking Cessation

Phase 2
Completed
Conditions
Smoking Cessation
Interventions
Drug: Gemfibrozil
Behavioral: smoking cessation counseling
First Posted Date
2015-12-23
Last Posted Date
2019-02-01
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
16
Registration Number
NCT02638597
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Parkland Memorial Hospital, Dallas, Texas, United States

Investigating Veregen โ„ข 15% Ointment Treatment For Non-facial Verrucae in Pediatric Patients: A Pilot Study

Phase 4
Completed
Conditions
Verruca, Warts
Interventions
Procedure: Cryotherapy and Veregen
Drug: Veregen only
First Posted Date
2015-12-04
Last Posted Date
2017-09-08
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
28
Registration Number
NCT02622568
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UTSW Department of Dermatology, Dallas, Texas, United States

Phenytoin for Memory Impairment Secondary to Megestrol

Phase 4
Completed
Conditions
Cognitive Impairment
Interventions
Drug: Phenytoin 200 mg capsule
Drug: Megestrol 800 mg liquid
Drug: Phenytoin-matched Placebo capsule
Drug: Megestrol-matched liquid Placebo
First Posted Date
2015-11-03
Last Posted Date
2019-09-09
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
21
Registration Number
NCT02595723
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UT Southwestern Medical Center, Dallas, Texas, United States

Improving Chronic Disease Management With Pieces

Not Applicable
Completed
Conditions
Type 2 Diabetes
Chronic Kidney Disease
Diabetes
Hypertension
High BP
Interventions
Other: Collaborative Model of Primary care and Subspecialty care
First Posted Date
2015-10-27
Last Posted Date
2024-04-02
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
18268
Registration Number
NCT02587936
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Veteran's Administration, Dallas, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Parkland Health and Hospital System, Dallas, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

ProHealth, Farmington, Connecticut, United States

and more 1 locations

Effectiveness of Manual Therapy and Exercise in Shoulder OA

Not Applicable
Withdrawn
Conditions
Osteoarthritis
Interventions
Procedure: physical therapy
First Posted Date
2015-10-27
Last Posted Date
2019-09-13
Lead Sponsor
University of Texas Southwestern Medical Center
Registration Number
NCT02587559
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UT Southwestern Medical Center, Dallas, Texas, United States

Predictors of Depression Treatment Response to Exercise

Phase 3
Completed
Conditions
Depression
Major Depressive Disorder
Interventions
Behavioral: Exercise
First Posted Date
2015-10-22
Last Posted Date
2019-04-01
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
38
Registration Number
NCT02583867
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UT Southwestern Medical Center, Dallas, Texas, United States

Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP)

Completed
Conditions
Gastrointestinal Cancer
Gynecologic Cancer
Lung Cancer
Skin Cancer
Endocrine Cancer
Breast Cancer
Genitourinary Cancer
Leukemia
Male Genital Cancer
First Posted Date
2015-10-22
Last Posted Date
2018-05-11
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
32
Registration Number
NCT02583815
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UT Southwestern Medical Center, Dallas, Texas, United States

Texas Hepatocellular Carcinoma Consortium (THCCC) Project 5

Not Applicable
Completed
Conditions
Carcinoma, Hepatocellular
Liver Neoplasms
Interventions
Behavioral: Outreach with patient education and patient navigation services
First Posted Date
2015-10-21
Last Posted Date
2022-09-28
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
2871
Registration Number
NCT02582918
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Texas Southwestern Medical Center, Dallas, Texas, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath